FMP

FMP

Enter

DFFN - Diffusion Pharmaceuticals Inc.

Profile of Diffusion Pharmaceuticals Inc.(DFFN), Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance t

photo-url-https://financialmodelingprep.com/image-stock/DFFN.png

Diffusion Pharmaceuticals Inc.

DFFN

NASDAQ

4.4 USD

0.41 (9.32%)

About

ceo

Dr. Robert J. Cobuzzi Jr., Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://www.diffusionpharma.com

exchange

NASDAQ

Description

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

CIK

0001053691

ISIN

US15713L1098

CUSIP

253748305

Address

300 East Main Street

Phone

434 220 0718

Country

US

Employee

13

IPO Date

May 23, 2008

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep